Status:
UNKNOWN
Outcomes of Emotion Regulation Therapy in Young Autistic Adults
Lead Sponsor:
Michal Assaf
Conditions:
Autism
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This pilot study is designed to investigate the clinical outcomes and neural mechanisms of emotion regulation behavioral treatment , in a small sample of young adults diagnosed with autism spectrum di...
Detailed Description
Five young adults with ASD with emotional/behavioral challenges that are attributed to emotion dysregulation will be enrolled into an emotion regulation (ER) intervention administered twice weekly for...
Eligibility Criteria
Inclusion
- Diagnosis of Autism Spectrum Disorder
- Ages 18-40
- Estimated full-scale IQ ≥ 80
- T score \> 60 on either the externalizing or internalizing symptoms scores of either the Adult Behavior Checklist (ABC-L) or the Adult Self Report (ASR)
- Participation in previous study at the Olin Center ("Social Emotional Study"; E-HHC- 2018-0241)
Exclusion
- Intellectual disability (estimated full scale IQ\<80
- History of a significant head injury (severe concussion, hospitalization)
- History of neurosurgery
- History of epilepsy, stroke, MS, a neurodegenerative disorder, or any other neurological disorder
- A current major medical condition (e.g. cancer, heart failure)
- Current substance use (determined by urine screen done to all participants before each MRI scan)
- In-body metal implants (e.g. surgical clips, certain pacemakers) or history of exposure to metal shards or other MRI contraindications
- Pregnancy
Key Trial Info
Start Date :
July 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2023
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05341505
Start Date
July 15 2022
End Date
January 30 2023
Last Update
October 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Living, Hartford Hospital
Hartford, Connecticut, United States, 06106